Genprex Stock (NASDAQ:GNPX)
Previous Close
$6.99
52W Range
$6.51 - $129.50
50D Avg
$11.19
200D Avg
$15.43
Market Cap
$4.44M
Avg Vol (3M)
$706.87K
Beta
-0.69
Div Yield
-
GNPX Company Profile
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.